
Mana Bio
Mana.bio is an AI-based drug delivery startup specializing in programmable drug delivery and gene therapy, with a focus on lipid nanoparticles (LNPs), RNA-based therapeutics, DNA therapeutics, and vaccines.
$20M Seed ·
Source: startupintros.com
Funding history ↓Signals
Website registeredFeb 27, 2019 (7 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | $20M | — | startupintros.com |
Timeline
- Website created
Founders and team
YD
Yogev Debbi Co-Founder & CEOsource: mana.bioRN
Roy Nevo Co-Founder & CTOsource: mana.bioAS
Avi Schroeder Scientific co-foundersource: mana.bioKR
Kira Radinsky Scientific co-foundersource: mana.bio
Companies like Mana Bio
EEVis BiosciencePre Seed · Feb 2026
SSilver Spur TherapeuticsAAxelyfSeed · Oct 2026
EeTheRNA Immunotherapies$39M Series B+ · Aug 2022
PParticella
TTubulis$360M Series B+ · Oct 2025
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/mana-bio (get a free API key).